In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 >/=14 d after the 2nd dose. Chagla Z. Ann Intern Med 2021 Mar 2. doi: 10.7326/ACPJ202103160.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chagla Z. In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 >/=14 d after the 2nd dose. Ann Intern Med 2021 Mar 2. doi: 10.7326/ACPJ202103160.
PMID: 33646836